Prevalence of and molecular basis for tuberculosis drug resistance in the republic of georgia: Validation of a QIAplex system for detection of drug resistance-related mutations

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 725-729

  Gegia, Medea ^a   Mdivani, Nino ^a   Mendes, Rodrigo E ^c   Li, Haijing ^d   Akhalaia, Maka ^b   Han, Jian ^c   Khechinashvili, George ^a   Tang, Yi Wei ^d,e  

^a Georgian Foundation Against Tuberculosis and Lung Diseases   (Georgia)

^b National Center of Tuberculosis and Lung Diseases   (Georgia)

^c QIAGEN North America   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC RESISTANCE; GEORGIA (REPUBLIC); HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; KATG GENE; MULTIDRUG RESISTANCE; MUTATOR GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RPOB GENE; RPSL GENE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; GEORGIA (REPUBLIC); HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; SENSITIVITY AND SPECIFICITY; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 38649122083     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01124-07     Document Type: Article

References (17)

1. Aerts, A., M. Habouzit, L. Mschiladze, N. Malakmadze, N. Sadradze, O. Menteshashvili, F. Portaels, and P. Sudre. 2000. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int. J. Tuberc. Lung Dis. 4:1104-1110.
2. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55:301-305.
3. Cooksey, R. C., G. P. Morlock, A. McQueen, S. E. Glickman, and J. T. Crawford. 1996. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob. Agents Chemother. 40:1186-1188.
4. Han, J., D. C. Swan, S. J. Smith, S. H. Lum, S. E. Sefers, E. R. Unger, and Y. W. Tang. 2006. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J. Clin. Microbiol. 44:4157-4162.
5. Hazbon, M. H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, C. I. Leon, M. Bose, F. Chaves, M. Murray, K. D. Eisenach, J. Sifuentes-Osornio, M. D. Cave, A. Ponce de Leon, and D. Alland. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649.
6. Hillemann, D., M. Weizenegger, T. Kubica, E. Richter, and S. Niemann. 2005. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43:3699-3703.
7. Kapur, V., L. L. Li, M. R. Hamrick, B. B. Plikaytis, T. M. Shinnick, A. Telenti, W. R. Jacobs, Jr., A. Banerjee, S. Cole, K. Y. Yuen, et al. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med. 119:131-138.
8. Marttila, H. J., H. Soini, E. Eerola, E. Vyshnevskaya, B. I. Vyshnevskiy, T. F. Otten, A. V. Vasilyef, and M. K. Viljanen. 1998. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 42:2443-2445.
9. Meier, A., P. Kirschner, F. C. Bange, U. Vogel, and E. C. Bottger. 1994. Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob. Agents Chemother. 38:228-233.
10. Mokrousov, I., T. Otten, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40:3810-3813.
11. Nettleman, M. D. 2005. Multidrug-resistant tuberculosis: news from the front. JAMA 293:2788-2790.
12. Sreevatsan, S., X. Pan, K. E. Stockbauer, D. L. Williams, B. N. Kreiswirth, and J. M. Musser. 1996. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob. Agents Chemother. 40:1024-1026.
13. Srivastava, K., R. Das, P. Jakhmola, P. Gupta, D. S. Chauhan, V. D. Sharma, H. B. Singh, A. S. Sachan, and V. M. Katoch. 2004. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J. Med. Res. 120:100-105.
14. Tang, Y. W., S. Meng, H. Li, C. W. Stratton, T. Koyamatsu, and X. Zheng. 2004. PCR enhances acid-fast bacillus stain-based rapid detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 42:1849-1850.
15. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
16. Weinstock, D. M., O. Hahn, M. Wittkamp, K. A. Sepkowitz, G. Khechinashvili, and H. M. Blumberg. 2001. Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia. Int. J. Tuberc. Lung Dis. 5:164-169.
17. Yang, Z., R. Durmaz, D. Yang, S. Gunal, L. Zhang, B. Foxman, A. Sanic, and C. F. Marrs. 2005. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn. Microbiol. Infect. Dis. 53:201-208.